Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 295: C313-C323, 2008. First published June 18, 2008; doi:10.1152/ajpcell.00500.2007
0363-6143/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/C313    most recent
00500.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lockett, A.
Right arrow Articles by Harrington, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lockett, A.
Right arrow Articles by Harrington, M. A.

RECEPTORS AND SIGNAL TRANSDUCTION

Transient membrane recruitment of IRAK-1 in response to LPS and IL-1β requires TNF R1

Angelia Lockett,1,2 Mark G. Goebl,1 and Maureen A. Harrington1,2

Departments of 1Biochemistry and Molecular Biology and 2Cellular and Integrative Physiology, the Walther Oncology Center, Indiana University School of Medicine and the Walther Cancer Institute, Indianapolis, Indiana

Submitted 19 October 2007 ; accepted in final form 12 June 2008

The transcription factor NF-{kappa}B is an essential regulator of the innate immune response that functions as the first line of defense against infections. Activation of the innate immune response by bacterial lipopolysaccharide (LPS) triggers production of tumor necrosis factor-{alpha} (TNF-{alpha}) followed by interleukin-1 (IL-1). The IL-1 receptor associated kinase-1 (IRAK-1) is an integral component of the LPS, TNF-{alpha}, and IL-1 signaling pathways that regulate NF-{kappa}B. Thus we hypothesized that IRAK-1 coordinates cellular NF-{kappa}B responses to LPS, TNF-{alpha}, and IL-1. In contrast to TNF-{alpha} where IRAK-1 subcellular localization does not change, treatment with LPS or IL-1 leads to a loss in cytoplasmic IRAK-1 with a coordinate increase in plasma membrane associated modified IRAK-1. In fibroblasts lacking the type 1 TNF-{alpha} receptor (TNF R1), IRAK-1 turnover is altered and modification of IRAK-1 in the plasma membrane is decreased in response to LPS and IL-1, respectively. When NF-{kappa}B controlled gene expression is measured, fibroblasts lacking TNF R1 are hyperresponsive to LPS, whereas a more variable response to IL-1 is seen. Further analysis of the LPS response revealed that plasma membrane-associated IRAK-1 is found in Toll 4, IL-1, and TNF R1-containing complexes. The data presented herein suggest a model whereby the TNF R1-IRAK-1 interaction integrates the cellular response to LPS, TNF-{alpha}, and IL-1, culminating in a cell poised to activate TNF-{alpha}-dependent NF-{kappa}B controlled gene expression. In the absence of TNF R1-dependent events, exposure to LPS or IL-1 leads to hyperactivation of the inflammatory response.

TNF-{alpha}; cytokines; ubiquitinylation; cytoplasmic; phosphorylation



Address for reprint requests and other correspondence: M. A. Harrington, Dept. of Biochemistry & Molecular Biology, Indiana Univ. School of Medicine, 635 Barnhill Dr., MS 4071, Indianapolis, IN 46202-5122 (e-mail: mharrin{at}iupui.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.